Search clinical trials for: HPN424 2 Prime Step IV 300 ng/kg Target
Total 12 results
-
Harpoon TherapeuticsTerminatedAdvanced Prostate CancerUnited States, United Kingdom
-
Harpoon TherapeuticsCompletedAdvanced Cancers Associated With Mesothelin ExpressionUnited States
-
MacroGenicsTerminatedAMLUnited States, United Kingdom, Germany, Israel, Spain, France, Italy, Netherlands
-
ExCellThera inc.Memorial Sloan Kettering Cancer CenterRecruitingCord Blood Transplant | High Risk Myeloid MalignanciesUnited States
-
Institut CurieHoffmann-La Roche; Ministry of Health, France; Amgen; Pierre Fabre LaboratoriesActive, not recruitingPrimary Central Nervous System LymphomaFrance
-
Oslo University HospitalVestre Viken Hospital Trust; University of Oslo; The Research Council of Norway; University Hospital, Akershus and other collaboratorsRecruitingGlucose Metabolism Disorders | Impaired Glucose Tolerance | Insulin SensitivityNorway
-
Hospital for Special Surgery, New YorkCompletedTotal Hip ReplacementUnited States
-
Medical University of ViennaPolymun Scientific, Vienna, AustriaCompleted
-
Royal Marsden NHS Foundation TrustHoffmann-La Roche; Professor Cunningham's Clinical Research FundCompletedPancreatic CancerUnited Kingdom
-
National Institute of Allergy and Infectious Diseases...Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; AIDS Clinical Trials... and other collaboratorsCompletedCovid19 | CoronavirusUnited States, Argentina, Brazil, Guatemala, Mexico, Philippines, Puerto Rico, South Africa, Canada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingLymphoma | Acute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia | Lymphocytic NeoplasmUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Incyte CorporationActive, not recruitingPrimary Myelofibrosis | Secondary MyelofibrosisUnited States